THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the Lazard Capital Markets 8th Annual Healthcare Conference on Wednesday, November 16, 2011, at 10:30 a.m. EST. The conference will be held at The Pierre Hotel in New York City.
